Halozyme Therape Has Returned 45.2% Since SmarTrend Recommendation (HALO)

SmarTrend identified an Uptrend for Halozyme Therape (NASDAQ:HALO) on September 8th, 2017 at $13.07. In approximately 5 months, Halozyme Therape has returned 45.22% as of today's recent price of...